May 20, 2025

Muffy Walker, Author of "Memory Weavers"

Muffy Walker, Author of "Memory Weavers"

About This Episode

In this episode of BrainStorm by UsAgainstAlzheimer's Muffy Walker, a psychiatric nurse, founder of the International Bipolar Foundation, and author of the novel "Memory Weavers" discusses how her personal experiences caring for family members with both Alzheimer's disease and mental illness inspired her advocacy work. Her novel explores experiences of one person with Alzheimer's who loses memories and another with PTSD who can't escape traumatic memories. The conversation with host Meryl Comer delves into the persistent stigma surrounding both conditions, the challenges of caregiving, advances in early diagnosis through genetic testing, and intergenerational trauma impacts.

Walker highlights the importance of social connection in preventing cognitive decline and the isolation many caregivers experience as well as the valuable resources now available to patients and caregivers that weren't accessible when her mother was diagnosed 23 years ago. This is a must listen episode!

BrainStorm wants to hear from you! Send us a text.

Support the show

BrainStorm Feed

101

The Marriage Sabbatical - Finding Love and Living with MCI with Leah Fisher

This episode of BrainStorm, by UsAgainstAlzheimer’s, features host Meryl Comer interviewing Leah Fisher, a psychotherapist and author who took a bold year-long solo travel sabbatical at age 60 to explore different cultures while maintaining her marriage.
LISTEN NOW
100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW